• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Sunday, February 5, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Leibniz Prize for Claudia Höbartner

Bioengineer by Bioengineer
December 9, 2022
in Chemistry
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

It’s like a very big, early Christmas present that Würzburg chemist Claudia Höbartner can be happy about: The professor will receive one of the prestigious Gottfried Wilhelm Leibniz Prizes of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), combined with prize money of 2.5 million euros. The DFG made the announcement today.

Leibniz Prize for Claudia Höbartner

Credit: Institute of Organic Chemistry, University of Wuerzburg

It’s like a very big, early Christmas present that Würzburg chemist Claudia Höbartner can be happy about: The professor will receive one of the prestigious Gottfried Wilhelm Leibniz Prizes of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), combined with prize money of 2.5 million euros. The DFG made the announcement today.

“This is a big surprise I would never have expected. I am very happy that our team’s research receives this prestigious recognition,” says the head of the Chair of Organic Chemistry I at Julius-Maximilians-Universität Würzburg (JMU) in Bavaria, Germany.

Research at the interface between chemistry and biology

With the Leibniz Prizes, the DFG aims to improve the working conditions of outstanding scientists. Claudia Höbartner (44) will invest the prize money in further research into the biomolecules DNA and RNA – she and her team are leaders in this field at the interface between chemistry and biology. Their work can provide insights that can be used, for example, to fight infectious diseases.

One example: Together with colleagues from the Max Planck Institute for Multidisciplinary Sciences in Göttingen, the JMU researcher deciphered how the antiviral agents Remdesivir and Molnupiravir interfere with the reproduction of the SARS-CoV-2 virus. This knowledge can also be valuable for the development of drugs against other viral pathogens.

Catalytic functions of nucleic acids

Claudia Höbartner’s research focuses on the catalytic functions of the nucleic acids DNA and RNA. The two biomolecules can not only store, transport and regulate genetic information. They are also able to mediate the course of biochemical reactions like enzymes. Such RNA enzymes are called ribozymes and can be found in the laboratory by artificial evolution.

The professor has made groundbreaking discoveries in this field. Höbartner and her team developed the first RNA enzyme that makes a very specific modification to another RNA molecule, and they recently also uncovered the chemical mechanism of this new reaction. In addition, together with colleagues from Göttingen, she clarified the spatial structure of a DNA enzyme down to the atomic detail for the first time. This work proved that DNA also folds into complex three-dimensional shapes in order to be catalytically active – just as protein enzymes do.

Successful research attracts young people

With such cutting-edge work, Claudia Höbartner has had a decisive influence on her field of research. She has found new approaches to specifically modify nucleic acids, and she has developed innovative methods to investigate enzymatically active DNA and RNA.

Her successful research attracts many young people to Würzburg: Höbartner’s group currently hosts scientists from eight nations. The professor has already published more than 80 papers in leading chemistry journals, but also in top interdisciplinary journals such as those of the Nature group. The Leibniz Prize money should give this success story an additional boost.

Career of the Leibniz Prize winner

Claudia Höbartner, born in 1977 in Krems in Austria, studied Technical Chemistry at the Vienna University of Technology. She completed her diploma thesis in Switzerland at ETH Zurich, after which she went to the University of Innsbruck to do her doctorate. In 2005 she moved to the University of Illinois in Urbana-Champaign (USA) as a postdoc.

Höbartner came to Germany in 2008: she took over the leadership of a research group at the Max Planck Institute for Biophysical Chemistry in Göttingen. She also worked as a chemistry professor at the university there for two years. From Göttingen, she moved to JMU in July 2017 as head of the Chair of Organic Chemistry I.



Share12Tweet8Share2ShareShareShare2

Related Posts

Jeffrey Rimer, University of Houston Abraham E. Dukler Professor of Chemical Engineering

During dolphin research, UH engineer discovers new method to possibly improve pharmaceuticals

February 3, 2023
Dr Egle Klumbyte

Researchers: Energy-efficient construction materials work better in colder climates

February 3, 2023

The power of theory: Finding an efficient electrocatalyst for hydrogen peroxide synthesis

February 3, 2023

Robots and A.I. team up to discover highly selective catalysts

February 3, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Health Equity Report Card pilot project to help close the care gap highlighted on World Cancer Day

Tech that turns household surfaces into touch sensors is a touch closer to application

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In